{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:10:36Z","timestamp":1780488636313,"version":"3.54.1"},"reference-count":49,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Korean government (MSIT)","award":["2022M3A9G1014476"],"award-info":[{"award-number":["2022M3A9G1014476"]}]},{"name":"Korean government (MSIT)","award":["RS-2023-00227084"],"award-info":[{"award-number":["RS-2023-00227084"]}]},{"name":"Korean government (MSIT)","award":["HR18C0016"],"award-info":[{"award-number":["HR18C0016"]}]},{"name":"Korean government (MSIT)","award":["NRF-2021R1A2B5B03001891"],"award-info":[{"award-number":["NRF-2021R1A2B5B03001891"]}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022M3A9G1014476"],"award-info":[{"award-number":["2022M3A9G1014476"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00227084"],"award-info":[{"award-number":["RS-2023-00227084"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["HR18C0016"],"award-info":[{"award-number":["HR18C0016"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A2B5B03001891"],"award-info":[{"award-number":["NRF-2021R1A2B5B03001891"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Ministry of Health and Welfare, Republic of Korea","doi-asserted-by":"publisher","award":["2022M3A9G1014476"],"award-info":[{"award-number":["2022M3A9G1014476"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Ministry of Health and Welfare, Republic of Korea","doi-asserted-by":"publisher","award":["RS-2023-00227084"],"award-info":[{"award-number":["RS-2023-00227084"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Ministry of Health and Welfare, Republic of Korea","doi-asserted-by":"publisher","award":["HR18C0016"],"award-info":[{"award-number":["HR18C0016"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Ministry of Health and Welfare, Republic of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A2B5B03001891"],"award-info":[{"award-number":["NRF-2021R1A2B5B03001891"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022M3A9G1014476"],"award-info":[{"award-number":["2022M3A9G1014476"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00227084"],"award-info":[{"award-number":["RS-2023-00227084"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["HR18C0016"],"award-info":[{"award-number":["HR18C0016"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A2B5B03001891"],"award-info":[{"award-number":["NRF-2021R1A2B5B03001891"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Target identification is a crucial process in drug development, aiming to identify key proteins, genes, and signal pathways involved in disease progression and their relevance in potential therapeutic interventions. While C-C chemokine receptor 8 (CCR8) has been investigated as a candidate anti-cancer target, comprehensive multi-omics analyzes across various indications are limited. In this study, we conducted an extensive bioinformatics analysis integrating genomics, proteomics, and transcriptomics data to establish CCR8 as a promising anti-cancer drug target. Our approach encompassed data collection from diverse knowledge resources, gene function analysis, differential gene expression profiling, immune cell infiltration assessment, and strategic prioritization of target indications. Our findings revealed strong correlations between CCR8 and specific cancers, notably Breast Invasive Carcinoma (BRCA), Colon Adenocarcinoma (COAD), Head and Neck Squamous Cell Carcinoma (HNSC), Rectum adenocarcinoma (READ), Stomach adenocarcinoma (STAD), and Thyroid carcinoma (THCA). This research advances our understanding of CCR8 as a potential target for anti-cancer drug development, bridging the gap between molecular insights and creating opportunities for personalized treatment of solid tumors.<\/jats:p>","DOI":"10.3390\/biomedicines11112910","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T09:56:36Z","timestamp":1698400596000},"page":"2910","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["CCR8 as a Therapeutic Novel Target: Omics-Integrated Comprehensive Analysis for Systematically Prioritizing Indications"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5384-9540","authenticated-orcid":false,"given":"Nari","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Research Institute, Trial Informatics Inc., Seoul 05544, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhee","family":"Pyo","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chungbuk National University, Cheongju 28644, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Min","family":"Lee","sequence":"additional","affiliation":[{"name":"Samjin Pharmaceutical Co., Ltd., Seoul 04054, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9300-3945","authenticated-orcid":false,"given":"Ji-Sung","family":"Jang","sequence":"additional","affiliation":[{"name":"Biomedical Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7925-0333","authenticated-orcid":false,"given":"Do-Wan","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1532-5970","authenticated-orcid":false,"given":"Kyung Won","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea"},{"name":"Research Institute, Trial Informatics Inc., Seoul 05544, Republic of Korea"},{"name":"Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1084\/jem.20032152","article-title":"Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes","volume":"200","author":"Qu","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e2114282119","DOI":"10.1073\/pnas.2114282119","article-title":"CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory","volume":"119","author":"Kidani","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3390\/cancers14030511","article-title":"Chemokine Receptor-Targeted Therapies: Special Case for CCR8","volume":"14","author":"Moser","year":"2022","journal-title":"Cancers"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/imm.13337","article-title":"CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function","volume":"163","author":"Whiteside","year":"2021","journal-title":"Immunology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune disease","volume":"19","author":"Hafler","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"808347","DOI":"10.3389\/fimmu.2022.808347","article-title":"The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/mab.2021.0005","article-title":"Development of Anti-Mouse CC Chemokine Receptor 8 Monoclonal Antibodies for Flow Cytometry","volume":"40","author":"Tanaka","year":"2021","journal-title":"Monoclon. Antib. Immunodiagn. Immunother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1158\/0008-5472.CAN-20-3585","article-title":"Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models","volume":"81","author":"Campbell","year":"2021","journal-title":"Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/bib\/bbz122","article-title":"An omics perspective on drug target discovery platforms","volume":"21","author":"Paananen","year":"2020","journal-title":"Brief. Bioinform."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nrd1202","article-title":"Target discovery","volume":"2","author":"Lindsay","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1831211","DOI":"10.1155\/2022\/1831211","article-title":"Comprehensive Analysis of Genomic and Expression Data Identified Potential Markers for Predicting Prognosis and Immune Response in CRC","volume":"2022","author":"He","year":"2022","journal-title":"Genet. Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Xu, J., Zhang, W., Zhang, P., Sun, W., Han, Y., and Li, L. (2023). A comprehensive analysis of copy number variations in diverse apple populations. BMC Genom., 24.","DOI":"10.1186\/s12864-023-09347-9"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"22036","DOI":"10.1038\/s41598-021-01508-8","article-title":"Integrative Bioinformatics approaches to therapeutic gene target selection in various cancers for Nitroglycerin","volume":"11","author":"Chinnappan","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1021\/acs.jmedchem.3c00030","article-title":"Discovery of a Potent and Selective CCR8 Small Molecular Antagonist IPG7236 for the Treatment of Cancer","volume":"66","author":"Wu","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1172\/JCI12655","article-title":"The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics","volume":"107","author":"Papi","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1158\/1535-7163.MCT-22-0570","article-title":"S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells","volume":"22","author":"Nagira","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1038\/s41598-023-31276-6","article-title":"Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing","volume":"13","author":"Islam","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/cam4.1301","article-title":"Biological signaling pathways and potential mathematical network representations: Biological discovery through optimization","volume":"7","author":"Isaza","year":"2018","journal-title":"Cancer Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Karimizadeh, E., Sharifi-Zarchi, A., Nikaein, H., Salehi, S., Salamatian, B., Elmi, N., Gharibdoost, F., and Mahmoudi, M. (2019). Analysis of gene expression profiles and protein-protein interaction networks in multiple tissues of systemic sclerosis. BMC Med. Genom., 12.","DOI":"10.1186\/s12920-019-0632-2"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Tian, L., Chen, T., Lu, J., Yan, J., Zhang, Y., Qin, P., Ding, S., and Zhou, Y. (2021). Integrated Protein-Protein Interaction and Weighted Gene Co-expression Network Analysis Uncover Three Key Genes in Hepatoblastoma. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.631982"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: A graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) project","volume":"45","author":"Consortium","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/pro.3307","article-title":"The human protein atlas: A spatial map of the human proteome","volume":"27","author":"Thul","year":"2018","journal-title":"Protein Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pediatrneurol.2014.10.006","article-title":"Pilot validation of the tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist","volume":"52","author":"Leclezio","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gui, T., Yao, C., Jia, B., and Shen, K. (2021). Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0253136"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"36652","DOI":"10.1074\/jbc.M605584200","article-title":"Structure\/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist","volume":"281","author":"Fox","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Miller, H.E., and Bishop, A.J.R. (2021). Correlation AnalyzeR: Functional predictions from gene co-expression correlations. BMC Bioinform., 22.","DOI":"10.1186\/s12859-021-04130-7"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/nar\/gkg034","article-title":"STRING: A database of predicted functional associations between proteins","volume":"31","author":"Huynen","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","article-title":"Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap","volume":"14","author":"Reimand","year":"2019","journal-title":"Nat. Protoc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e001749","DOI":"10.1136\/jitc-2020-001749","article-title":"Therapeutic depletion of CCR8(+) tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy","volume":"9","author":"Dombrecht","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.7150\/jca.35901","article-title":"Clinical Implications of Tumor-Infiltrating Immune Cells in Breast Cancer","volume":"10","author":"Zhang","year":"2019","journal-title":"J. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.21037\/tcr-20-1937","article-title":"KIF4A is a promising prognostic marker and correlates with immune infiltration in clear cell renal cell carcinoma","volume":"9","author":"Li","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Lou, S., Zhang, J., Yin, X., Zhang, Y., Fang, T., Wang, Y., and Xue, Y. (2022). Comprehensive Characterization of Tumor Purity and Its Clinical Implications in Gastric Cancer. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.782529"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12943-020-01234-1","article-title":"Regulatory T cells in tumor microenvironment: New mechanisms, potential therapeutic strategies and future prospects","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12935-018-0712-y","article-title":"Analysis of PD-1 related immune transcriptional profile in different cancer types","volume":"18","author":"Shang","year":"2018","journal-title":"Cancer Cell Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.2147\/CMAR.S238174","article-title":"Comprehensive Analysis of PD-1 Gene Expression, Immune Characteristics and Prognostic Significance in 1396 Glioma Patients","volume":"12","author":"Liu","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41416-023-02181-6","article-title":"Immune checkpoint inhibitor combinations-current and emerging strategies","volume":"128","author":"Walsh","year":"2023","journal-title":"Br. J. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1182\/bloodadvances.2021006512","article-title":"CCR8 is a new therapeutic target in cutaneous T-cell lymphomas","volume":"6","author":"Giustiniani","year":"2022","journal-title":"Blood Adv."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/2040620716636541","article-title":"Mogamulizumab for the treatment of cutaneous T-cell lymphoma: Recent advances and clinical potential","volume":"7","author":"Duvic","year":"2016","journal-title":"Ther. Adv. Hematol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1080\/10428194.2022.2043300","article-title":"Prediction of the risk for graft versus host disease after allogeneic hematopoietic stem cell transplantation in patients treated with mogamulizumab","volume":"63","author":"Kamada","year":"2022","journal-title":"Leuk. Lymphoma"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Lu, R.-M., Hwang, Y.-C., Liu, I.-J., Lee, C.-C., Tsai, H.-Z., Li, H.-J., and Wu, H.-C. (2020). Development of therapeutic antibodies for the treatment of diseases. J. Biomed. Sci., 27.","DOI":"10.1186\/s12929-019-0592-z"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","article-title":"Small molecules in targeted cancer therapy: Advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fimmu.2019.00168","article-title":"Cold Tumors: A Therapeutic Challenge for Immunotherapy","volume":"10","author":"Bonaventura","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e1226","DOI":"10.1002\/cti2.1226","article-title":"Therapeutic strategies to remodel immunologically cold tumors","volume":"9","author":"Wang","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Karin, N. (2021). Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?. Cancers, 13.","DOI":"10.3390\/cancers13246317"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/11\/2910\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:12:42Z","timestamp":1760130762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/11\/2910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["biomedicines11112910"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines11112910","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,27]]}}}